BACTROBAN SUMMARY
BACTROBAN CREAM (mupirocin calcium cream, 2%) contains the dihydrate crystalline calcium hemi-salt of the antibiotic mupirocin.
BACTROBAN CREAM is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10Â cm in length or 100Â cm2 in area) due to susceptible strains of S.
aureus and S.
pyogenes.
Â
|
|
NEWS HIGHLIGHTS
Published Studies Related to Bactroban (Mupirocin Topical)
A randomized trial of mupirocin sinonasal rinses versus saline in surgically
recalcitrant staphylococcal chronic rhinosinusitis. [2012] STUDY DESIGN: Prospective, double-blinded, placebo-controlled study... CONCLUSIONS: Mupirocin sinonasal rinses are an effective short-term anti-S aureus
A Randomized Controlled Trial Comparing Mupirocin and Polysporin Triple Ointments in Peritoneal Dialysis Patients: The MP3 Study. [2011.12.01] Background and objectivesInfectious complications remain a significant cause of peritoneal dialysis (PD) technique failure. Topical ointments seem to reduce peritonitis; however, concerns over resistance have led to a quest for alternative agents...
The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. [2010.12] BACKGROUND: HIV-positive patients at HELP/PSI, Inc, an in-patient drug rehabilitation center, had a high baseline prevalence of Staphylococcus aureus colonization (49%) and incidence of infection (17%) in a previous year-long study... CONCLUSIONS: Monthly application of nasal mupirocin significantly decreased S. aureus colonization in HIV patients in residential drug rehabilitation. Monthly mupirocin application has a potential role in long-term care settings or in HIV-positive patients with high rates of S. aureus colonization and infection.
The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): A Randomized Controlled Trial of Monthly Mupirocin in HIV-Infected Individuals. [2010.08.03] BACKGROUND:: HIV-positive patients at HELP/PSI, Inc, an in-patient drug rehabilitation center, had a high baseline prevalence of Staphylococcus aureus colonization (49%) and incidence of infection (17%) in a previous year-long study... CONCLUSIONS:: Monthly application of nasal mupirocin significantly decreased S. aureus colonization in HIV patients in residential drug rehabilitation. Monthly mupirocin application has a potential role in long-term care settings or in HIV-positive patients with high rates of S. aureus colonization and infection.
A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population. [2009.09] BACKGROUND: Intranasal mupirocin or Polysporin Triple (PT) ointment (polymyxin B, bacitracin, gramicidin), in combination with chlorhexidine body washes, have been used for eradicating methicillin-resistant Staphylococcus aureus (MRSA), but no comparative studies have been done... CONCLUSION: Both agents demonstrated poor efficacy and PT was significantly less efficacious than mupirocin at 12 weeks in eradicating MRSA from all sites.
Clinical Trials Related to Bactroban (Mupirocin Topical)
A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban� Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions. [Completed]
The primary objective of this study is to determine the comparability of the safety and
efficacy of Mupirocin Calcium Cream, 2% and Bactroban® Cream in subjects with secondarily
infected traumatic skin lesions. It will also be determined whether the efficacy of each of
the active treatments is superior to that of the vehicle cream (placebo).
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment) [Completed]
This study will assess the nasal eradication of SA in healthy subjects following treatment
with mupirocin 2% (Bactroban 2% Nasal Ointment) twice daily for 5 days, by means of a
broth enriched culture microbial assay. The sensitivities of broth enrichment and plating
assay methods will be compared. The safety and tolerability of Bactroban 2% Nasal Ointment
will also be assessed.
Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection [Completed]
Staphylococcus aureus is a bacteria that causes serious, often life threatening infections
including pneumonia, wound, and bloodstream infections. Persons with AIDS are at high risk
for S. aureus infections. They are also at high risk for nasal carriage of S. aureus. In
fact, nasal carriage is a known risk factor for subsequent S. aureus infection. Topical
mupirocin, an antibiotic when applied to the anterior nares, is a safe, effective way to
eliminate S. aureus colonization. Some studies have shown that mupirocin can also decrease
the risk of S. aureus infection, but many of those studies utilized historical controls and
none were rigorously tested among AIDS patients over an extended period of time.
The main purpose of this randomized, double-blinded, placebo controlled study is to
determine if mupirocin can eliminate S. aureus nasal colonization in residents at PSI
(inpatient, drug rehabilitation facility for AIDS patients in the Bronx.) PSI residents
currently have a high incidence of S. aureus nasal colonization and infection. Nasal
cultures followed by twice daily application of mupirocin vs. placebo for five days will be
performed on a monthly basis for 8 months. the study will examine whether mupirocin
decreases the incidence of S. aureus infections and prevents S. aureus nasal colonization.
The study is important because it may show that mupirocin is an effective way to eliminate
nasal colonization and prevent S. aureus infections in AIDS patients, among those at highest
risk for serious S. aureus infection.
Hypothesis: Monthly application of mupirocin will reduce nasal colonization with S. aureus
Efficacy Study of Mupirocin on Infection After Coronary Artery Bypass Grafting [Completed]
The hypothesis is that application of Mupirocin to the nose before and after coronary artery
bypass grafting surgery will reduce the incidence of surgical site infections.
Prevention of Surgical Site Infections: Effectiveness of Nasal Povidone-Iodine and Nasal Mupirocin [Completed]
We hypothesize the application of mupirocin or povidone-iodine to the nares is equally
effective in short term Staphylococcus aureus(SA)suppression. Our overall study objective
is to measure the rate of deep and superficial Surgical Site Infections (SSIs) after primary
hip, knee, shoulder and elbow arthroplasty surgery and primary spinal fusion surgery
requiring implantation of prosthetic material, when the patient receives either nasal
mupirocin or nasal povidone-iodine prior to surgery.
Secondary study objectives include:
1. Measure hospital length of stay and re-admission rates in the mupirocin and
povidone-iodine groups.
2. Measure adverse events related to mupirocin and povidone-iodine.
3. Measure rate of SA resistance to mupirocin.
Reports of Suspected Bactroban (Mupirocin Topical) Side Effects
Drug Ineffective (14),
Hypersensitivity (12),
Condition Aggravated (12),
Pruritus (11),
Rash Pruritic (11),
Infection (10),
Constipation (10),
Blood Cholesterol Increased (10),
Rash Pustular (10),
Rash Papular (10), more >>
|
PATIENT REVIEWS / RATINGS / COMMENTSBased on a total of 1 ratings/reviews, Bactroban has an overall score of 6. The effectiveness score is 4 and the side effect score is 2. The scores are on ten point scale: 10 - best, 1 - worst.
| Bactroban review by 52 year old female patient | | Rating |
Overall rating: | |           |
Effectiveness: | | Marginally Effective |
Side effects: | | Extremely Severe Side Effects | | Treatment Info |
Condition / reason: | | amputee, constant sores on stump |
Dosage & duration: | | antibiotic creams as needed (dosage frequency: all most all the time) for the period of since seventeen when I lost my leg |
Other conditions: | | infections |
Other drugs taken: | | siezure meds | | Reported Results |
Benefits: | | to eliminate sores on stump and siezures |
Side effects: | | tried everything to know avail. |
Comments: | | I put some of Mary Kay night solution on my stump on it and low and behold it was almost cleared up over night. Would love to tell you more about it. Reach me at my e-mail address: coleensundberg@gmail.com or my home phone 218-346-6987. My daughter started selling Mary Kay, Thank you sincerely, Coleen Sundberg, Perham, MN 56573 |
|
|
Page last updated: 2013-02-10
|